0172 Neoadjuvant gemcitabine plus doxorubicin (G+A) versus FAC regimen for locally advanced breast cancer patients (phase III randomized study)

✍ Scribed by H.M. El-Zawahry; R.M. Gaffar; H.M. Abdel Raouf; E.A. Fikary; H.M. Ramadan; H.A. Ezzat

• Book ID: 114316301
• Publisher: Elsevier Science
• Year: 2009
• Tongue: English
• Weight: 51 KB
• Volume: 18
• Category: Article
• ISSN: 0960-9776
• DOI: 10.1016/s0960-9776(09)70195-x